RaySearch yesterday announced it received FDA 510(k) clearance for its RayStation 8B treatment planning system.
The RayStation 8B is a machine learning treatment planning system for the radiation oncology market. The system uses deep neural networks and is designed for automated treatment planning and automated organ segmentation to improve efficiency and consistency. The framework of the system allows the machine learning models to be trained using available data from the clinic. Pre-trained models provided by RaySearch can also be used.
“This clearance is a major step towards unlacing the unlimited potential of oncology software, led by RaySearch. More sophisticated automation means increased usability, efficiency and patient safety,” founder and CEO Johan Löf said in a press release. “This allows resources and clinicians to be focused on more challenging cases, education and such. Continuous development within oncology software is a key component in tomorrow’s patient specific care plan.”
The company said that RayStation supports a number of treatment machines to provide one control center for all treatment planning needs.